Residency · Denver, CO
Sponsored by University of Colorado School of Medicine
Allergic Rhinitis: A Review.
JAMA · 2024 · 234 citations · Joshua Bernstein
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Lancet (London, England) · 2025 · 96 citations · Matthew Germinaro
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial.
The lancet. Gastroenterology & hepatology · 2023 · 224 citations · Matthew Germinaro
Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults.
American journal of respiratory and critical care medicine · 2024 · 121 citations · Eileen Wang
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2024 · 86 citations · Eileen Wang, Flavia Hoyte, Nicholas Chapman
Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
Chest · 2021 · 244 citations · Eileen Wang
Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis.
JAMA · 2025 · 50 citations · Flavia Hoyte
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
Gastroenterology · 2022 · 179 citations · Matthew Germinaro